Cargando…
Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America
BACKGROUND: Despite the abundance of information concerning ocrelizumab in phase III clinical trials, there is scarce evidence regarding real-world patient profiles. OBJECTIVE: The aim of this study was to investigate patient profiles, effectiveness and persistence with treatment among patients who...
Autores principales: | ROJAS, Juan Ignacio, PATRUCCO, Liliana, FRUNS, Manuel, HORNUNG, Giesela, FLORES, José, CARNERO CONTENTTI, Edgar, LOPEZ, Pablo Adrian, PETTINICCHI, Juan Pablo, CARIDE, Alejandro, GALLEGUILLOS, Lorna, BARAHONA, Jorge, DIAZ, Violeta, HERNÁNDEZ, Marianella, ALONSO, Ricardo, CRISTIANO, Edgardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academia Brasileira de Neurologia - ABNEURO
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231439/ https://www.ncbi.nlm.nih.gov/pubmed/34133511 http://dx.doi.org/10.1590/0004-282X-ANP-2020-0339 |
Ejemplares similares
-
Influenza vaccination status in multiple sclerosis patients from Latin America
por: Rojas, Juan I., et al.
Publicado: (2021) -
An Abnormally High Neutrophil-to-Lymphocyte Ratio Is Not an Independent Outcome Predictor in AQP4-IgG-Positive NMOSD
por: Carnero Contentti, Edgar, et al.
Publicado: (2021) -
Reversible splenial lesion syndrome: A differential diagnosis of corpus callosum lesions
por: García Fernández, Cynthia, et al.
Publicado: (2018) -
Family planning in Argentinian women with multiple sclerosis: An important yet seldom approached issue
por: Alonso, Ricardo, et al.
Publicado: (2021) -
Assessing attacks and treatment response rates among adult patients
with NMOSD and MOGAD: Data from a nationwide registry in
Argentina
por: Contentti, Edgar Carnero, et al.
Publicado: (2021)